Literature DB >> 18252201

Uselessness of anti-actin antibody in celiac disease screening.

Elisa Fabbro1, Laura Rubert, Sara Quaglia, Fortunato Ferrara, Valentina Kiren, Alessandro Ventura, Tarcisio Not.   

Abstract

BACKGROUND: Serum anti-actin IgA antibodies (AAA) were identified in patients with celiac disease (CD), and a close correlation emerged between the presence of AAA and mucosa damage, but test for AAA found in celiacs have a wide range of sensitivity and specificity values. AIM: To compare 1) the sensitivity and specificity of untreated, calcium-chelated and heated sera from 102 celiacs, 52 sick patients and 103 healthy controls in the determination of AAA, and 2) the reliability of AAA with anti-transglutaminase antibodies (anti-tTG) in diagnosing celiac disease and in predicting intestinal damage. The intestinal derived AAA was isolated by using the phage-display library technique.
RESULTS: Treated sera was significantly more sensitive than untreated (p=0.0001), and showed a significant correlation between AAA and the three degrees (3a, 3b, 3c) of intestinal damage (p=0.01). Sensitivity and specificity values of anti-tTG assay were higher than the AAA assay, and anti-tTG serum-concentration was only significantly correlated with more severe (3b and 3c) intestinal damage degrees. AAA isolated by phage display showed similar results of serum AAA in immunofluorescence assay.
CONCLUSIONS: Notwithstanding correlation between AAA and celiac disease, AAA assay, also after treatments, has little to offer in screening for CD compared to the well-established anti-transglutaminase assay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252201     DOI: 10.1016/j.cca.2008.01.015

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Detection of autoantibodies against actin filaments in celiac disease.

Authors:  B Porcelli; F Ferretti; C Vindigni; C Scapellato; L Terzuoli
Journal:  J Clin Lab Anal       Date:  2013-01-04       Impact factor: 2.352

Review 2.  Serum markers in the clinical management of celiac disease.

Authors:  Marlou Adriaanse; Daniel A Leffler
Journal:  Dig Dis       Date:  2015-04-22       Impact factor: 2.404

3.  IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.

Authors:  Elena Bazzigaluppi; Barbara Parma; Giulia M Tronconi; Patrizia Corsin; Luca Albarello; Stefano Mora; Graziano Barera
Journal:  Ital J Pediatr       Date:  2010-03-18       Impact factor: 2.638

4.  Anti-actin IgA antibodies identify celiac disease patients with a Marsh 3 intestinal damage among subjects with moderate anti-TG2 levels.

Authors:  Enrico Schirru; Fabrice Danjou; Lucia Cicotto; Rossano Rossino; Maria Doloretta Macis; Rosanna Lampis; Rita-Désirée Jores; Mauro Congia
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.